Author:
Cox C.E.,Drylie D.M.,Klimberg I.,Childs S.J.,Wegenke J.D.,Malek G.H.,Harrison L.H.,McCullough D.L.,Finegold S.M.,George W.L.,Petersen E.A.,Paulson D.F.,Rigby O.F.,Markowitz S.M.,Crane L.R.,Siporin C.,Wajszczuk C.P.
Publisher
Ovid Technologies (Wolters Kluwer Health)
Reference19 articles.
1. Structure-activity relationships of 4-oxo-1,8-naphthyridine-3-carboxylic acids including AT-2266, a new oral antipseudomonal agent. Current Chemotherapy and Infectious Diseases, 11th ICC Proc.;Matsumoto;Amer. Soc. Microbiol.,1980
2. In vitro and in vivo antibacterial activity of AT-2266;Nakamura;Chemotherapy,1984
3. In vitro activity of enoxacin, a quinolone carboxylic acid, compared with those of norfloxacin new β,-lactams aminoglycosides and trimethoprim;Chin;Antimicrob. Agents Chemother.,1983
4. In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid;Nakamura;Antimicrob. Agents Chemother.,1983
5. In-vitro activity of enoxacin (CI-919), a new quinolone derivative compared with that of other antimicrobial agents;Wise;J. Antimicrob. Chemother.,1984
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献